Predictive role of ferroptosis-related long non-coding RNAs in bladder cancer and their association with immune microenvironment and immunotherapy response

Abstract Background We have previously reported that ferroptosis has an important role in bladder cancer development. In this study, we aimed to further explore the possible predictive ability of ferroptosis-related long non-coding RNAs (lncRNAs) in bladder cancer and their relation with immune micr...

Full description

Bibliographic Details
Main Authors: Jingchao Liu, Zhipeng Zhang, Xiaodong Liu, Wei Zhang, Lingfeng Meng, Jiawen Wang, Zhengtong Lv, Haoran Xia, Yaoguang Zhang, Jianye Wang
Format: Article
Language:English
Published: BMC 2022-02-01
Series:World Journal of Surgical Oncology
Subjects:
Online Access:https://doi.org/10.1186/s12957-022-02514-4
_version_ 1818981900349341696
author Jingchao Liu
Zhipeng Zhang
Xiaodong Liu
Wei Zhang
Lingfeng Meng
Jiawen Wang
Zhengtong Lv
Haoran Xia
Yaoguang Zhang
Jianye Wang
author_facet Jingchao Liu
Zhipeng Zhang
Xiaodong Liu
Wei Zhang
Lingfeng Meng
Jiawen Wang
Zhengtong Lv
Haoran Xia
Yaoguang Zhang
Jianye Wang
author_sort Jingchao Liu
collection DOAJ
description Abstract Background We have previously reported that ferroptosis has an important role in bladder cancer development. In this study, we aimed to further explore the possible predictive ability of ferroptosis-related long non-coding RNAs (lncRNAs) in bladder cancer and their relation with immune microenvironment and immunotherapy response. Materials and methods The ferroptosis-related lncRNAs were identified by Pearson’s correlation analysis. The predictive lncRNA signature was developed by univariate and multivariate regression analyses. Only the main effects of independent variables in multivariate analysis were included in this signature. The TCGA dataset was defined as the training cohort and GEO was the validation cohort in this study. All samples were grouped into a high- or low-risk group depending on risk signature. The prognostic role of lncRNA signature was explored through survival analysis and receiver operating characteristic curve (ROC) analysis in both TCGA and GEO cohorts. Additionally, the independent prognostic ability of the lncRNA signature was confirmed by multivariate independent analysis. Furthermore, the relationship between lncRNAs and immune microenvironment as well as immunotherapy response in bladder cancers was studied. Results The Kaplan–Meier curves identified significantly poorer overall survival outcomes for high-risk groups in both TCGA (p < 0.001) and GEO (p < 0.001) cohorts. The area under the curve (AUC) during ROC analysis of 1, 3, and 5 years was 0.781 ± 0.046, 0.784 ± 0.027, and 0.817 ± 0.025, respectively, in the TCGA cohort and 0.665 ± 0.177, 0.719 ± 0.068, and 0.791 ± 0.055, respectively, in the GEO cohort. The multivariate independent analysis in TCGA cohort identified age (p = 0.003), stage (p < 0.001), and signature risk score (p < 0.001) as independent risk factors for overall survival. Furthermore, this study demonstrated a significant difference in infiltration levels of various immune cells between high- and low-risk groups. The high risk group tended to have a lower expression of proteins including PD1 (p < 0.01), PD-L1 (p < 0.01), CTLA-4 (p < 0.05), etc. corresponding to various immune checkpoints. Additionally, the immunotherapy trial confirmed that the high-risk group tended to have a poorer treatment response than the low-risk group (p < 0.001). Conclusions The ferroptosis-related lncRNAs exhibited a good predictive capacity for overall survival in bladder cancer. Additionally, they could be utilized to reveal tumour-immune microenvironment and immunotherapy responses.
first_indexed 2024-12-20T17:38:40Z
format Article
id doaj.art-770cd170e42c4d48a5576e5f452471a8
institution Directory Open Access Journal
issn 1477-7819
language English
last_indexed 2024-12-20T17:38:40Z
publishDate 2022-02-01
publisher BMC
record_format Article
series World Journal of Surgical Oncology
spelling doaj.art-770cd170e42c4d48a5576e5f452471a82022-12-21T19:31:10ZengBMCWorld Journal of Surgical Oncology1477-78192022-02-0120111710.1186/s12957-022-02514-4Predictive role of ferroptosis-related long non-coding RNAs in bladder cancer and their association with immune microenvironment and immunotherapy responseJingchao Liu0Zhipeng Zhang1Xiaodong Liu2Wei Zhang3Lingfeng Meng4Jiawen Wang5Zhengtong Lv6Haoran Xia7Yaoguang Zhang8Jianye Wang9Department of Urology, Beijing Hospital, National Center of Gerontology, Institute of Geriatric Medicine, Chinese Academy of Medical SciencesDepartment of Urology, Beijing Hospital, National Center of Gerontology, Institute of Geriatric Medicine, Chinese Academy of Medical SciencesDepartment of Urology, Beijing Hospital, National Center of Gerontology, Institute of Geriatric Medicine, Chinese Academy of Medical SciencesDepartment of Urology, Beijing Hospital, National Center of Gerontology, Institute of Geriatric Medicine, Chinese Academy of Medical SciencesDepartment of Urology, Beijing Hospital, National Center of Gerontology, Institute of Geriatric Medicine, Chinese Academy of Medical SciencesDepartment of Urology, Beijing Hospital, National Center of Gerontology, Institute of Geriatric Medicine, Chinese Academy of Medical SciencesDepartment of Urology, Beijing Hospital, National Center of Gerontology, Institute of Geriatric Medicine, Chinese Academy of Medical SciencesDepartment of Urology, Beijing Hospital, National Center of Gerontology, Institute of Geriatric Medicine, Chinese Academy of Medical SciencesDepartment of Urology, Beijing Hospital, National Center of Gerontology, Institute of Geriatric Medicine, Chinese Academy of Medical SciencesDepartment of Urology, Beijing Hospital, National Center of Gerontology, Institute of Geriatric Medicine, Chinese Academy of Medical SciencesAbstract Background We have previously reported that ferroptosis has an important role in bladder cancer development. In this study, we aimed to further explore the possible predictive ability of ferroptosis-related long non-coding RNAs (lncRNAs) in bladder cancer and their relation with immune microenvironment and immunotherapy response. Materials and methods The ferroptosis-related lncRNAs were identified by Pearson’s correlation analysis. The predictive lncRNA signature was developed by univariate and multivariate regression analyses. Only the main effects of independent variables in multivariate analysis were included in this signature. The TCGA dataset was defined as the training cohort and GEO was the validation cohort in this study. All samples were grouped into a high- or low-risk group depending on risk signature. The prognostic role of lncRNA signature was explored through survival analysis and receiver operating characteristic curve (ROC) analysis in both TCGA and GEO cohorts. Additionally, the independent prognostic ability of the lncRNA signature was confirmed by multivariate independent analysis. Furthermore, the relationship between lncRNAs and immune microenvironment as well as immunotherapy response in bladder cancers was studied. Results The Kaplan–Meier curves identified significantly poorer overall survival outcomes for high-risk groups in both TCGA (p < 0.001) and GEO (p < 0.001) cohorts. The area under the curve (AUC) during ROC analysis of 1, 3, and 5 years was 0.781 ± 0.046, 0.784 ± 0.027, and 0.817 ± 0.025, respectively, in the TCGA cohort and 0.665 ± 0.177, 0.719 ± 0.068, and 0.791 ± 0.055, respectively, in the GEO cohort. The multivariate independent analysis in TCGA cohort identified age (p = 0.003), stage (p < 0.001), and signature risk score (p < 0.001) as independent risk factors for overall survival. Furthermore, this study demonstrated a significant difference in infiltration levels of various immune cells between high- and low-risk groups. The high risk group tended to have a lower expression of proteins including PD1 (p < 0.01), PD-L1 (p < 0.01), CTLA-4 (p < 0.05), etc. corresponding to various immune checkpoints. Additionally, the immunotherapy trial confirmed that the high-risk group tended to have a poorer treatment response than the low-risk group (p < 0.001). Conclusions The ferroptosis-related lncRNAs exhibited a good predictive capacity for overall survival in bladder cancer. Additionally, they could be utilized to reveal tumour-immune microenvironment and immunotherapy responses.https://doi.org/10.1186/s12957-022-02514-4FerroptosislncRNABladder cancerImmunotherapyImmune microenvironment
spellingShingle Jingchao Liu
Zhipeng Zhang
Xiaodong Liu
Wei Zhang
Lingfeng Meng
Jiawen Wang
Zhengtong Lv
Haoran Xia
Yaoguang Zhang
Jianye Wang
Predictive role of ferroptosis-related long non-coding RNAs in bladder cancer and their association with immune microenvironment and immunotherapy response
World Journal of Surgical Oncology
Ferroptosis
lncRNA
Bladder cancer
Immunotherapy
Immune microenvironment
title Predictive role of ferroptosis-related long non-coding RNAs in bladder cancer and their association with immune microenvironment and immunotherapy response
title_full Predictive role of ferroptosis-related long non-coding RNAs in bladder cancer and their association with immune microenvironment and immunotherapy response
title_fullStr Predictive role of ferroptosis-related long non-coding RNAs in bladder cancer and their association with immune microenvironment and immunotherapy response
title_full_unstemmed Predictive role of ferroptosis-related long non-coding RNAs in bladder cancer and their association with immune microenvironment and immunotherapy response
title_short Predictive role of ferroptosis-related long non-coding RNAs in bladder cancer and their association with immune microenvironment and immunotherapy response
title_sort predictive role of ferroptosis related long non coding rnas in bladder cancer and their association with immune microenvironment and immunotherapy response
topic Ferroptosis
lncRNA
Bladder cancer
Immunotherapy
Immune microenvironment
url https://doi.org/10.1186/s12957-022-02514-4
work_keys_str_mv AT jingchaoliu predictiveroleofferroptosisrelatedlongnoncodingrnasinbladdercancerandtheirassociationwithimmunemicroenvironmentandimmunotherapyresponse
AT zhipengzhang predictiveroleofferroptosisrelatedlongnoncodingrnasinbladdercancerandtheirassociationwithimmunemicroenvironmentandimmunotherapyresponse
AT xiaodongliu predictiveroleofferroptosisrelatedlongnoncodingrnasinbladdercancerandtheirassociationwithimmunemicroenvironmentandimmunotherapyresponse
AT weizhang predictiveroleofferroptosisrelatedlongnoncodingrnasinbladdercancerandtheirassociationwithimmunemicroenvironmentandimmunotherapyresponse
AT lingfengmeng predictiveroleofferroptosisrelatedlongnoncodingrnasinbladdercancerandtheirassociationwithimmunemicroenvironmentandimmunotherapyresponse
AT jiawenwang predictiveroleofferroptosisrelatedlongnoncodingrnasinbladdercancerandtheirassociationwithimmunemicroenvironmentandimmunotherapyresponse
AT zhengtonglv predictiveroleofferroptosisrelatedlongnoncodingrnasinbladdercancerandtheirassociationwithimmunemicroenvironmentandimmunotherapyresponse
AT haoranxia predictiveroleofferroptosisrelatedlongnoncodingrnasinbladdercancerandtheirassociationwithimmunemicroenvironmentandimmunotherapyresponse
AT yaoguangzhang predictiveroleofferroptosisrelatedlongnoncodingrnasinbladdercancerandtheirassociationwithimmunemicroenvironmentandimmunotherapyresponse
AT jianyewang predictiveroleofferroptosisrelatedlongnoncodingrnasinbladdercancerandtheirassociationwithimmunemicroenvironmentandimmunotherapyresponse